Q4 2020 Morphic Holding Inc Earnings Call Transcript
Excuse me, ladies and gentlemen, this is the operator. My name is Myra. Thank you for standing by and welcome to the Morphic Financial and Operational Results 2020 Year-End Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. (Operator Instructions).
With that I would now like to hand the conference over to our first speaker, Chris Erdman, Senior Vice President of Communications. Thank you, and please go ahead.
Thank you, Myra, and good morning, everyone. Thanks for attending Morphic's first investor call. Today, we will review our 2020 operational and financial results and also provide an update on the ongoing Phase 1 clinical trial of MORF-057.
A little housekeeping. This morning, we issued two press releases. The first reported results for the fourth quarter and full-year ended December 31, 2020, and the second announced the preliminary positive results from the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |